Literature DB >> 19239821

The role of urethral dilation in managing pediatric neurogenic bladder dysfunction.

Julian Wan1.   

Abstract

Urethral dilation is an effective method of treating children with neurogenic bladders who have poor bladder compliance, high leak point pressure, and are unresponsive to standard therapy with anticholinergic medications and clean intermittent catheterization. Urethral dilation can be successfully applied to boys and girls and has few side effects. There are no demonstrated long-term effects on continence. However, the use of urethral dilation has been limited by two factors: 1) general disregard given to urethral dilation when applied to children and adults with recurrent urinary tract infections and lower urinary tract symptoms, and 2) the general efficacy of conventional therapy that limits the number of children who may actually benefit from the procedure.

Entities:  

Mesh:

Year:  2009        PMID: 19239821     DOI: 10.1007/s11934-009-0027-6

Source DB:  PubMed          Journal:  Curr Urol Rep        ISSN: 1527-2737            Impact factor:   3.092


  20 in total

1.  Urethral dilation as treatment for neurogenic bladder.

Authors:  Darcie A Kiddoo; Douglas A Canning; Howard M Snyder; Michael C Carr
Journal:  J Urol       Date:  2006-10       Impact factor: 7.450

2.  Urethral dilation improves bladder compliance in children with myelomeningocele and high leak point pressures.

Authors:  D A Bloom; J M Knechtel; E J McGuire
Journal:  J Urol       Date:  1990-08       Impact factor: 7.450

3.  Myelodysplasia with severe neonatal hydronephrosis: the value of urethral dilatation.

Authors:  S J Shochat; A D Perlmutter
Journal:  J Urol       Date:  1972-01       Impact factor: 7.450

4.  Clean, intermittent self-catheterization in the treatment of urinary tract disease.

Authors:  J Lapides; A C Diokno; S J Silber; B S Lowe
Journal:  J Urol       Date:  1972-03       Impact factor: 7.450

5.  A review of 402 girls with recurrent urinary tract infection.

Authors:  A J Wein; H W Schoenberg
Journal:  J Urol       Date:  1972-02       Impact factor: 7.450

6.  The obstructed neurogenic bladder in the newborn.

Authors:  J H Johnston; B L Kathel
Journal:  Br J Urol       Date:  1971-04

7.  External urethral sphincter dilation for the management of high risk myelomeningocele: 15-year experience.

Authors:  J M Park; E J McGuire; H P Koo; A C Schwartz; C K Garwood; D A Bloom
Journal:  J Urol       Date:  2001-06       Impact factor: 7.450

8.  Temporary perineal urethrostomy for external sphincter dilation in a male patient with high risk myelomeningocele.

Authors:  David C Miller; David A Bloom; Edward J McGuire; John M Park
Journal:  J Urol       Date:  2003-10       Impact factor: 7.450

9.  Upper urinary tract deterioration in patients with myelodysplasia and detrusor hypertonia: a followup study.

Authors:  E J McGuire; J R Woodside; T A Borden
Journal:  J Urol       Date:  1983-04       Impact factor: 7.450

10.  The practice of urethral dilation for voiding dysfunction among fellows of the Section on Urology of the American Academy of Pediatrics.

Authors:  Adam R Metwalli; Earl Y Cheng; Bradley P Kropp; John C Pope
Journal:  J Urol       Date:  2002-10       Impact factor: 7.450

View more
  1 in total

1.  Challenges in pediatric urologic practice: a lifelong view.

Authors:  John S Wiener; Nina Huck; Anne-Sophie Blais; Mandy Rickard; Armando Lorenzo; Heather N McCaffrey Di Carlo; Margaret G Mueller; Raimund Stein
Journal:  World J Urol       Date:  2020-04-23       Impact factor: 4.226

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.